Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study

André, T; Shiu, KK; Kim, TW; Jensen, BV; Jensen, LH; Punt, CJA; Smiths, D; Garcia-Carbonero, R; Alcaide-Garcia, J; Gibbs, P; de la Fouchardiere, C; Rivera, F; Elez, E; Le, DT; Yoshino, T; Zuo, Y; Fogelmans, D; Adelbergs, D; Diaz, LA – 2025 – 10.1016/j.annonc.2024.11.012